| Nitin Garg, MBBS | |
|
10825 W Mcdowell Rd, Suite 310, Avondale, AZ 85392 | |
| (602) 641-9486 | |
| (480) 500-8430 |
| Full Name | Nitin Garg |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 22 Years |
| Location | 10825 W Mcdowell Rd, Avondale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891914206 | NPI | - | NPPES |
| 340143 | Medicaid | SC | |
| ENROLLED | Medicaid | MN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
A ground-breaking device to help patients with dizziness problems has moved a step forward following a successful research study.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.
Australian led global guidelines for the diagnosis and treatment of the primary cause of infertility in women will be published simultaneously in three international journals, supported by a suite of health professional and patient resources to improve health outcomes for women with PCOS.
The dentate gyrus is a likely site of pathology underlying schizophrenia, shows a study published in Molecular Psychiatry.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 4 days ago
| Entity Name | Hardin Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306894704 PECOS PAC ID: 9739191628 Enrollment ID: O20060614000061 |
News Archive
A ground-breaking device to help patients with dizziness problems has moved a step forward following a successful research study.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.
Australian led global guidelines for the diagnosis and treatment of the primary cause of infertility in women will be published simultaneously in three international journals, supported by a suite of health professional and patient resources to improve health outcomes for women with PCOS.
The dentate gyrus is a likely site of pathology underlying schizophrenia, shows a study published in Molecular Psychiatry.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 4 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
A ground-breaking device to help patients with dizziness problems has moved a step forward following a successful research study.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.
Australian led global guidelines for the diagnosis and treatment of the primary cause of infertility in women will be published simultaneously in three international journals, supported by a suite of health professional and patient resources to improve health outcomes for women with PCOS.
The dentate gyrus is a likely site of pathology underlying schizophrenia, shows a study published in Molecular Psychiatry.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nitin Garg, MBBS 10825 W Mcdowell Rd, Suite 310, Avondale, AZ 85392 Ph: (602) 641-9486 | Nitin Garg, MBBS 10825 W Mcdowell Rd, Suite 310, Avondale, AZ 85392 Ph: (602) 641-9486 |
News Archive
A ground-breaking device to help patients with dizziness problems has moved a step forward following a successful research study.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.
Australian led global guidelines for the diagnosis and treatment of the primary cause of infertility in women will be published simultaneously in three international journals, supported by a suite of health professional and patient resources to improve health outcomes for women with PCOS.
The dentate gyrus is a likely site of pathology underlying schizophrenia, shows a study published in Molecular Psychiatry.
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
› Verified 4 days ago
Dr. Joseph Di Como, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 13055 W Mcdowell Rd Ste G112, Avondale, AZ 85392 Phone: 623-312-3020 Fax: 623-487-6747 |